Uploaded March 2023 | Updated September 2026, 3 days ago
Associate Professor Jennifer Rodger is associated with the University of Western Australia and the Perron Institute for Neurological and Translational Science.
In people with multiple sclerosis (MS), high levels of inflammation are thought to cause the death of a specific type of brain cell called oligodendrocytes, resulting in a loss of brain function.
Associate Professor Jennifer Rodger and her team recently showed that repetitive transcranial magnetic stimulation (rTMS) can improve the survival of oligodendrocytes in the brain. However, the brain is a very complex organ that contains many different types of cells that interact with each other.
Their aim is to identify the cellular targets of rTMS so that future experiments can.
- More effectively identify the precise factors that are responsible for oligodendrocyte survival.
- Design treatments that will maximise survival of oligodendrocytes to rescue brain function in people with MS.
Associate Professor Jennifer Rodger is associated with the University of Western Australia and the Perron Institute for Neurological and Translational Science.
In people with multiple sclerosis (MS), high levels of inflammation are thought to cause the death of a specific type of brain cell called oligodendrocytes, resulting in a loss of brain function.
Associate Professor Jennifer Rodger and her team recently showed that repetitive transcranial magnetic stimulation (rTMS) can improve the survival of oligodendrocytes in the brain. However, the brain is a very complex organ that contains many different types of cells that interact with each other.
Their aim is to identify the cellular targets of rTMS so that future experiments can.
- More effectively identify the precise factors that are responsible for oligodendrocyte survival.
- Design treatments that will maximise survival of oligodendrocytes to rescue brain function in people with MS.
